Related Experiment Video
Updated: Jul 17, 2026
05:14
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
MR spectroscopy in neurodegenerative disease
1Movement Disorders Clinic, University of Alberta / Glenrose Rehabilitation Hospital, Edmonton, Alberta, Canada. wayne.martin@ualberta.ca
Molecular Imaging and Biology
|February 7, 2007
Summary
Magnetic resonance spectroscopy (MRS) offers a non-tracer method for molecular imaging, analyzing metabolites in neurodegenerative diseases like Parkinson's and Alzheimer's. This technique provides insights into neuronal and glial markers, aiding in disease diagnosis and understanding.
Area of Science:
- Neuroimaging
- Biochemistry
- Neurology
Background:
- Traditional molecular imaging uses tracers, while magnetic resonance spectroscopy (MRS) leverages nuclear behavior in magnetic fields.
- MRS measures the resonant frequency of nuclei based on their chemical environment.
- Proton spectroscopy is common in brain research, often measuring N-acetylaspartate as a neuronal marker.
Purpose of the Study:
- To review the application of magnetic resonance spectroscopy (MRS) in neurodegenerative disorders.
- To highlight MRS's ability to quantify various metabolites beyond N-acetylaspartate.
- To discuss the utility of 31P-MRS for assessing tissue bioenergetics in vivo.
Main Methods:
- Utilizing magnetic resonance spectroscopy (MRS) to analyze specific nuclei within a magnetic field.
- Applying proton (1H) MRS to quantify metabolites like N-acetylaspartate, myo-inositol, glutamate, glutamine, and gamma-aminobutyric acid.
- Employing phosphorus-31 (31P) MRS to assess high-energy phosphate metabolites and tissue bioenergetic status.
Main Results:
- MRS allows for in vivo quantification of neuronal markers (N-acetylaspartate) and other key metabolites (myo-inositol, glutamate, glutamine, GABA).
- 31P-MRS provides insights into the bioenergetic status of tissues.
- These spectroscopic techniques are applicable to studying neurodegenerative conditions.
Conclusions:
- Magnetic resonance spectroscopy (MRS) is a valuable non-tracer imaging technique for neurodegenerative disorders.
- MRS enables the assessment of neuronal health, glial function, neurotransmitter levels, and tissue bioenergetics.
- The review covers applications in Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis.
Related Concept Videos
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:25Applications Of NMR In Biology
Nuclear magnetic resonance (NMR) spectroscopy is a very valuable analytical technique for researchers. It has been used for more than 50 years as an analytical tool. F. Bloch and E. Purcell formulated NMR in 1946 and won the 1952 Nobel Prize in Physics for their work. Biological macromolecules such as proteins, nucleic acids, lipids, and organic molecules including pharmaceutical compounds, can be studied using this versatile tool that exploits the magnetic properties of certain nuclei.
The...
The...